Explore how DEGRONOPEDIA is revolutionizing protein degradation research through systematic degron discovery and analysis.
Discover the groundbreaking research revealing how ALS and FTD, once thought to be separate conditions, are actually two manifestations of the same underlying disease process.
Exploring how computational drug design identifies promising compounds from soursop to combat cancer by targeting the PirH2 protein.
Discover how chemically induced nuclear pore complex protein degradation via TRIM21 is revolutionizing targeted protein degradation therapies for cancer and neurodegenerative diseases.
Discover how the loss of KDM5A epigenetic regulator accelerates KRAS-driven pancreatic cancer progression and impacts treatment strategies.
Discover how scientists are engineering protease-resistant β-hairpin peptides to detect cancer activity with unprecedented precision.
Exploring Long QT Syndrome, a silent electrical disorder of the heart that can cause sudden cardiac arrest in otherwise healthy individuals.
Discover how the APOSPORY locus in Hypericum perforatum could transform agriculture through apomixis research and genetic cloning in plants.
Discover how targeting the UCHL1 protein disrupts cancer's ability to thrive in low-oxygen environments and prevents tumor growth and metastasis.
Discover how scientists are turning the SUMO1 cancer protein shield into a kill signal using PROTAC degraders, offering new hope for cancer treatment.